Peter M. Ravdin
Division of Medical Oncology
University of Texas Health Sciences Center at San Antonio
USA
Name/email consistency: high
- Hormone Replacement Therapy and the Increase in the Incidence of Invasive Lobular Cancer. Ravdin, P.M. Breast. Dis (2009)
- Prognosis of patients with resected non-small cell lung cancer: impact of clinical and pathologic variables. Ravdin, P.M., Davis, G. Lung. Cancer (2006)
- A method for making estimates of the benefit of the late use of letrozole in patients completing 5 years of tamoxifen. Ravdin, P.M., Davis, G.J. Clin. Breast Cancer (2004)
- Managing the risk of osteoporosis in women with a history of early breast cancer. Ravdin, P.M. Oncology (Williston Park, N.Y.) (2004)
- Is Her2 of value in identifying patients who particularly benefit from anthracyclines during adjuvant therapy? A qualified yes. Ravdin, P.M. J. Natl. Cancer Inst. Monographs (2001)